SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shepko Jonathan
(Last) (First) (Middle)
15455 DALLAS PARKWAY
SUITE 550
(Street)
ADDISON TX 75001
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Daseke, Inc. [ DSKE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO
3. Date of Earliest Transaction (Month/Day/Year)
12/31/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/31/2023 M 61,561 A $0.00(1) 443,571 D
Common Stock 12/31/2023 F 24,225 D $8.1 419,346 D
Common Stock 12/31/2023 M 29,433 A $0.00(2) 448,779 D
Common Stock 12/31/2023 F 11,582 D $8.1 437,197 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 12/31/2023 M 61,561 (1) (1) Common Stock 61,561 $0.00 288,042 D
Restricted Stock Unit (2) 12/31/2023 M 29,433 (2) (2) Common Stock 29,433 $0.00 258,609 D
Explanation of Responses:
1. On August 2, 2021, the Reporting Person received 184,645 restricted stock units ("RSUs") (61,542 of which vested on August 2, 2022; 61,542 of which vested on January 1, 2023; and 61,561 of which vested on December 31, 2023). The RSUs that vested on December 31, 2023 were initially scheduled to vest on January 1, 2024; the vesting date of such RSUs was accelerated in order to mitigate impacts that could arise under Section 280G of the Internal Revenue Code of 1986, as amended (the "Code"). Each RSU represented a contingent right to receive one share of the Issuer's common stock. Upon vesting, RSUs were settled in shares of the Issuer's common stock.
2. On February 28, 2022, the Reporting Person received 88,308 RSUs (29,433 of which vested on March 1, 2023; 29,433 of which vested on December 31, 2023; and 29,442 of which are scheduled to vest on January 1, 2025). The RSUs that vested on December 31, 2023 were initially scheduled to vest on January 1, 2024; the vesting date of such RSUs was accelerated in order to mitigate impacts that could arise under Section 280G of the Code. Each RSU represented a contingent right to receive one share of the Issuer's common stock. Upon vesting, RSUs were settled in shares of the Issuer's common stock.
/s/ Soumit Roy, attorney-in-fact 01/03/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Daseke (NASDAQ:DSKE)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Daseke Charts.
Daseke (NASDAQ:DSKE)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Daseke Charts.